These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2437220)

  • 21. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.
    Tacket CO; Forrest B; Morona R; Attridge SR; LaBrooy J; Tall BD; Reymann M; Rowley D; Levine MM
    Infect Immun; 1990 Jun; 58(6):1620-7. PubMed ID: 1692807
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Clarkson KA; Porter CK; Talaat KR; Frenck RW; Alaimo C; Martin P; Bourgeois AL; Kaminski RW
    mSphere; 2021 Aug; 6(4):e0012221. PubMed ID: 34259559
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains.
    Viret JF; Cryz SJ; Lang AB; Favre D
    Mol Microbiol; 1993 Jan; 7(2):239-52. PubMed ID: 7680409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
    Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
    Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
    J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoenzyme analysis of typhoid-Shigella and Escherichia-Shigella hybrid vaccines and their parental strains.
    Schultz C
    J Clin Microbiol; 1989 Dec; 27(12):2838-41. PubMed ID: 2687324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel.
    Passwell JH; Harlev E; Ashkenazi S; Chu C; Miron D; Ramon R; Farzan N; Shiloach J; Bryla DA; Majadly F; Roberson R; Robbins JB; Schneerson R
    Infect Immun; 2001 Mar; 69(3):1351-7. PubMed ID: 11179298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen.
    Seid RC; Kopecko DJ; Sadoff JC; Schneider H; Baron LS; Formal SB
    J Biol Chem; 1984 Jul; 259(14):9028-34. PubMed ID: 6378905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.
    Cohen D; Ashkenazi S; Schneerson R; Farzam N; Bialik A; Meron-Sudai S; Asato V; Goren S; Baran TZ; Muhsen K; Gilbert PB; MacLennan CA
    Clin Microbiol Infect; 2023 Mar; 29(3):366-371. PubMed ID: 36243351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
    Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
    Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole genome analysis to detect potential vaccine-induced changes on Shigella sonnei genome.
    Behar A; Fookes MC; Goren S; Thomson NR; Cohen D
    Vaccine; 2015 Jun; 33(26):2978-83. PubMed ID: 25936664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans.
    Forrest BD; LaBrooy JT
    Vaccine; 1991 Jul; 9(7):515-20. PubMed ID: 1716810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine.
    Levenson VJ; Mallett CP; Hale TL
    Infect Immun; 1995 Jul; 63(7):2762-5. PubMed ID: 7790095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to Shigella sonnei in U.S. Marines.
    Mikhail MM; Mansour MM; Oyofo BA; Malone JD
    Infect Immun; 1996 Sep; 64(9):3942-5. PubMed ID: 8751956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of the O antigen of Shigella sonnei by a competitive immunoenzyme method].
    Voronov AV; Sazykin AIu; Vengerov IuIu; Serebriakov MIu; Malov VA
    Antibiot Khimioter; 1988 Jan; 33(1):43-6. PubMed ID: 2454084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stimulation of the secretory IgA system in monkeys by parenteral immunization with a ribosomal Sonne dysentery vaccine].
    Dzhikidze EK; Stasilevich ZK; Salamatova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):66-70. PubMed ID: 2462772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection.
    Xu DQ; Cisar JO; Osorio M; Wai TT; Kopecko DJ
    Vaccine; 2007 Aug; 25(33):6167-75. PubMed ID: 17629369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Infection; 1985; 13 Suppl 2():S206-10. PubMed ID: 3902655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral immunization with
    Shrivastava S; Agnememel AB; Ndungo E; Islam D; Liang Y; Frenck RW; Pasetti MF
    mSphere; 2024 Jan; 9(1):e0041923. PubMed ID: 38132716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.